This HTML5 document contains 154 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1182/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36443121
rdf:type
wikibase:Item
schema:description
2015年学术文章 naučni članak 2015년 논문 artigo científico (publicado na 2015) vědecký článek vitenskapelig artikkel tieteellinen artikkeli 2015年学术文章 2015年學術文章 artículu científicu espublizáu en 2015 مقالة علمية نشرت بتاريخ 26-10-2015 مقالهٔ علمی article scientifique (publié 2015) სამეცნიერო სტატია научная статья vetenskaplig artikel scienca artikolo գիտական հոդված 2015年学术文章 mokslinis straipsnis artikull shkencor наукова стаття, опублікована в жовтні 2015 vitskapeleg artikkel ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articol științific tudományos cikk artigo científico (publicado na 2015) 2015年學術文章 artigo científico artykuł naukowy мақолаи илмӣ bài báo khoa học vedecký článok 2015 nî lūn-bûn научни чланак wissenschaftlicher Artikel บทความทางวิทยาศาสตร์ научна статия 2015年學術文章 article scientific научни чланак scientific article 2015年學術文章 wetenschappelijk artikel 2015年の論文 teaduslik artikkel article científic מאמר מדעי мақолаи илмӣ 2015年學術文章 videnskabelig artikel (udgivet 2015) 2015年学术文章 επιστημονικό άρθρο 2015年学术文章 سائنسی مضمون articolo scientifico artículo científico publicado en 2015 bilimsel makale 2015年學術文章 artikulong pang-agham
p:P577
wds:Q36443121-410D910E-5CA9-4FFE-9E4A-F52343886027
wdt:P577
2015-10-26T00:00:00Z
p:P407
wds:Q36443121-4000AABC-66D2-4981-90EA-94BFC8FA3DAC
wdt:P407
wd:Q1860
p:P2860
wds:Q36443121-4A53A0DD-3385-4D8F-B316-3F540EA64017 wds:Q36443121-D33E3650-9C86-4DC6-8CCB-14C80F13FA13 wds:Q36443121-E1B19105-548E-4E91-A1EA-E693B8E238BF wds:Q36443121-E3F2E527-4950-473E-97EB-061BCB8ECC15 wds:Q36443121-E7F2C0C9-57D3-4293-9B65-81FBEB499CCF wds:Q36443121-F6995083-F5D3-4F47-86F2-66E16502FCE7 wds:Q36443121-FA41721D-1354-4C2D-9094-3E86360AE53E wds:Q36443121-90180BA7-71BB-4D8B-82AD-A4D718A04509 wds:Q36443121-99434545-7E62-4E30-9406-EB39E9C5F0DB wds:Q36443121-A8FBE63F-6C5D-41A8-B98D-9396E5B2E7AB wds:Q36443121-BB2021BE-38E9-42DB-AAC4-628F15B0DBD2 wds:Q36443121-1EB02A4E-C636-4EA2-A3C1-9F98EB07FBEC wds:Q36443121-288FFE16-8FFA-4BEA-93EE-B8AA591A0B12 wds:Q36443121-626A8F7C-C17A-412E-B7E9-232DB041247B wds:Q36443121-7A2EB97B-985C-4703-B87D-976E49A6E0B8 wds:Q36443121-4365A8CC-919C-4223-B52B-3B9157DA9B5B wds:Q36443121-479F046E-9394-44B1-AA22-D0313313E2A0
wdt:P2860
wd:Q37670054 wd:Q33411497 wd:Q24685850 wd:Q26799956 wd:Q24623371 wd:Q33417357 wd:Q41172796 wd:Q34239719 wd:Q24633207 wd:Q24632569 wd:Q24650472 wd:Q26829652 wd:Q34380652 wd:Q33944255 wd:Q28247732 wd:Q33717456 wd:Q28308285
p:P2093
wds:Q36443121-4DC6F60A-BB98-4F01-9CEF-CF4E01683DA0 wds:Q36443121-0E1B82D3-650F-489C-A90C-CFFA31F4CEC2 wds:Q36443121-DBA53D28-01BF-4778-8078-750C050CE061 wds:Q36443121-A45850B7-72AF-441B-9C1E-7955DCE2BC8D wds:Q36443121-74198962-A0E6-47B3-83D4-9C94DF9D30A2
wdt:P2093
Michele P Lambert Karen L Bride Jack J Bleesing James Casper Kim Smith-Whitley
rdfs:label
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
skos:prefLabel
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
schema:name
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
p:P50
wds:Q36443121-40EBD1BF-D2CB-4273-A7B7-038D8CE61CBB wds:Q36443121-57107EF1-F10F-43AA-A5AF-99305D5065ED wds:Q36443121-274C872A-5EA6-4CBD-908D-0F8F0F09203F wds:Q36443121-99B0B1A0-60C2-4D82-A57A-1D6C2CF5084E wds:Q36443121-C93A14CC-F986-4A03-9BCE-8DB59A5A7096
wdt:P50
wd:Q104495066 wd:Q117233463 wd:Q43166486 wd:Q82889836 wd:Q81433426
p:P1476
wds:Q36443121-54116113-34D8-4A90-9F9E-55BAA4B6B346
wdt:P1476
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
p:P304
wds:Q36443121-410A86F6-D8D8-448A-B488-BA163224D904
wdt:P304
17-28
p:P31
wds:Q36443121-4A23698E-C2A1-481E-B760-243A5FDEB0BF
wdt:P31
wd:Q13442814
p:P921
wds:Q36443121-5DEEBFFD-021F-4DBF-A209-BEB9D80308FB
wdt:P921
wd:Q32089
p:P698
wds:Q36443121-3B74467E-7851-42AA-AF82-D56FCE505942
wdtn:P698
n12:26504182
wdt:P698
26504182
p:P1433
wds:Q36443121-2444894E-E56A-4E1F-81DF-B4B9B60C40CE
wdt:P1433
wd:Q885070
p:P433
wds:Q36443121-9A5F0C38-AFB2-4782-A9D1-D18ACD3636E1
p:P478
wds:Q36443121-2A872A3A-63F9-424D-911D-3FF8503C3ADD
wdt:P433
1
wdt:P478
127
p:P356
wds:Q36443121-5B2C72B3-292B-4357-B59A-7A5A5FBF1A9F
wdtn:P356
n8:BLOOD-2015-07-657981
wdt:P356
10.1182/BLOOD-2015-07-657981
p:P8608
wds:Q36443121-B449DEF3-C847-436E-AE50-18F8CEC008B5
wdt:P8608
release_olco7v6ehncnbb43gnns34pzxa
p:P5875
wds:Q36443121-3BCCD6AE-D883-4AF7-934F-070ADD4822AB
wdt:P5875
283293008
p:P932
wds:Q36443121-4E1E6167-3E84-4715-9362-8234B1CFEBB0
wdt:P932
4705607